Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests-Reference-Cited by-同舟云学术

Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests

Published:2021-06 Issue:26 Volume:39 Page:3455-3458
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Eyal Nir,Gerhard Tobias,Strom Brian L.^ORCID

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference29 articles.

1. Callaway E. Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials. Nature. 2020. Epub 20 October. doi: 10.1038/d41586-020-02821-4.

2. Douglas AD, Hill AVS. Immunological considerations for SARS-CoV-2 human challenge studies. Nat Rev Immunol. 2020. Epub 21 October. doi: 10.1038/s41577-020-00472-0.

3. WHO Working Group for Guidance on Human Challenge Studies in COVID-19. Key criteria for the ethical acceptability of COVID-19 human challenge studies. Geneva: WHO, 2020 6 May. Report No.: Contract No.: WHO/2019-nCoV/Ethics_criteria/2020.1.

4. Britain first to infect healthy volunteers with coronavirus for study;Schwedes;DPA Int,2021

5. Human challenge trials of covid-19 vaccines still have much to teach us;Eyal;BMJ Opin,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research during Pandemics and Epidemics;The Oxford Handbook of Research Ethics;2022-09-21

2. Research ethics and public trust in vaccines: the case of COVID-19 challenge trials;Journal of Medical Ethics;2022-05-20

3. Pandemic vaccine testing: Combining conventional and challenge studies;Pharmacoepidemiology and Drug Safety;2022-03-31

4. Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review;ARCH ACAD EMERG MED;2022